What does Evolv Technologies do?
Evolv Technologies Holdings, Inc. is a Nasdaq-listed security technology company whose Class A stock trades as EVLV. It combines sensors, proprietary algorithms, cloud software, maintenance, and analytics to screen people and bags for concealed weapons at schools, hospitals, stadiums, workplaces, houses of worship, and public facilities.
Which products define the platform?
Evolv's official product overview identifies three connected layers. Evolv Express screens people as they walk through, identifies the person and location associated with a potential threat, and directs security staff to a targeted secondary search. Evolv eXpedite adds autonomous bag screening. Evolv Insights and the MyEvolv environment provide throughput, alert, settings, and system-performance data. This matters because the commercial offer is not merely a piece of detection hardware; it is a managed operating system for the entrance threshold.
| Element | Primary function | Economic role | Customer implication |
|---|---|---|---|
| Evolv Express | High-throughput people screening | Hardware sale or leased equipment plus recurring software and support | Reduces entry friction while retaining targeted secondary screening |
| Evolv eXpedite | Autonomous bag screening | Expands revenue per site and broadens the platform | Adds a bag-screening layer without a conventional staffed X-ray workflow |
| Insights and MyEvolv | Cloud analytics and fleet management | Supports recurring subscription value and switching costs | Turns entrance data into staffing and operating decisions |
Why does operating scale matter?
The company says customers tag more than 500 firearms daily and had tagged over 1.7 million weapons since 2021 by May 2026. That scale creates a large operating data set and makes throughput, uptime, alert quality, and analytics central to customer value. Evolv is therefore a technology-enabled security-as-a-service company with material hardware economics, not pure software.
How does Evolv make money, and which revenue stream matters most?
Evolv uses two main contract structures. In a pure subscription, it retains the equipment and recognizes recurring equipment, software, maintenance, and support revenue over a term typically lasting four years. In a purchase subscription, the customer buys hardware upfront and pays recurring software and service fees. Professional services add installation, training, and event support. License revenue declined after the Columbia arrangement ended on December 31, 2025.
What did the Q1 2026 revenue mix look like?
Why is mix more important than headline growth?
The Q1 2026 Form 10-Q shows sharply different economics by stream: subscription gross margin was 64%, service 74%, license and other 73%, and product only 12%. Customer-owned hardware can accelerate revenue and reduce leased-equipment funding, but it may dilute consolidated margin. The key trade-off is upfront growth versus recurring software-and-service economics.
| Revenue stream | Q1 2026 revenue | Q1 2026 gross margin | How to interpret it |
|---|---|---|---|
| Subscription | $23.1M | 64% | Largest and strategically most important recurring stream |
| Product | $13.4M | 12% | Boosts upfront revenue but carries low hardware margin |
| Service | $8.6M | 74% | High-margin installation, training, and operating support |
| License and other | $1.2M | 73% | Shrinking after the Columbia arrangement ended |
What did Evolv's latest quarter show?
The quarter ended March 31, 2026 is the latest official period before the scheduled August 11 second-quarter release. Evolv posted fast revenue and ARR growth, positive adjusted EBITDA, and a narrower operating loss. Yet GAAP net loss widened, operating cash flow stayed negative, and liquidity declined from year-end. Scaling improved; full self-funding did not.
How much did the income statement improve?
| Metric | Q1 2026 | Q1 2025 | Research interpretation |
|---|---|---|---|
| Revenue | $46.3M | $32.0M | 45% growth from new customers and expanded deployments |
| Gross profit | $23.6M | $14.8M | Scale improved dollars, while mix held margin near 51% |
| Operating loss | $(8.5)M | $(14.4)M | Operating margin improved to approximately (18.3)% |
| Net loss / diluted EPS | $(5.0)M / $(0.03) | $(1.7)M / $(0.01) | GAAP results remain affected by non-operating fair-value items |
| Operating cash flow | $(3.2)M | $(17.3)M | A major year-over-year improvement, but still a cash use |
What changed in guidance?
In the official Q1 2026 earnings release, management raised FY2026 revenue guidance to $175M-$180M, or 20%-23% growth, and ending ARR guidance to $145M-$150M, or 20%-25%. ARR annualizes recurring contract value; it is not GAAP revenue. Delivery depends on renewals, deployment timing, mix, and operating leverage.
Which turning points shaped Evolv's strategy?
Evolv's model reflects linked decisions to replace checkpoint-style screening with free-flow entrances, pair hardware with subscriptions, broaden from people to bags, and change manufacturing and fulfillment. These events explain today's installed base, revenue mix, and capital needs.
-
2013Evolv was founded around the idea that security screening could operate at the pace of normal life. That mission still drives product design and the emphasis on throughput and visitor experience.
-
2019Evolv Express launched. By March 2026, the company said the platform had screened more than four billion people, giving Evolv a large operating footprint and data asset.
-
2020A Motorola Solutions channel relationship expanded distribution reach. Evolv's filings describe access to more than 2,000 Motorola resellers and integration partners.
-
2021The company completed its business combination and began trading publicly as EVLV, creating access to public capital but also introducing warrants, earn-out shares, and later dilution considerations.
-
2024Evolv launched eXpedite for autonomous bag screening and appointed John Kedzierski CEO effective December 16. The product broadened the platform; the leadership change emphasized operating discipline and channel experience.
-
2025Evolv shifted more fulfillment and customer ownership in-house, ended the Columbia distribution and license arrangement, secured a $75M debt facility with $30M initially drawn, and selected Plexus as a contract manufacturer.
-
2026eXpedite received a DHS SAFETY Act designation in June, joining Express in the company's regulatory-positioning story and supporting a broader people-plus-bag screening offer.
Why did the 2025 model shift matter?
Ending the license-heavy distributor arrangement increased Evolv's direct exposure to customers, product revenue, inventory, receivables, manufacturing, and support. Q1 2026 license-fee revenue fell to $0.2M from $3.2M, while purchase subscriptions lifted product revenue. Greater customer control came with more operating complexity.
The Plexus manufacturing agreement announced in November 2025 is part of that transition. A diversified contract-manufacturing base can support scale and supply resilience, but onboarding parallel production can temporarily increase working capital, component commitments, and quality-control demands.
What gives Evolv a competitive advantage?
Evolv's potential moat combines high-throughput sensors, threat-location software, cloud analytics, field data, an installed fleet, service, and partner distribution. More deployments can deepen data and workflow integration. But security technology demands continuing proof of performance, reliability, and trust.
How does Evolv frame the competitive set?
Evolv's FY2025 Form 10-K defines competition by technology rather than named companies: walk-through metal detectors, handheld wands, magnetic-field, millimeter-wave, and terahertz systems. Customers compare checkpoint design, staffing, throughput, and detection trade-offs—not merely software features.
| Approach | Typical operating trade-off | Evolv's intended differentiation |
|---|---|---|
| Legacy walk-through detector | Can require single-file flow and more secondary checks | Higher-throughput, targeted alert localization, and analytics |
| Handheld screening | Labor intensive and difficult to scale at busy entrances | Automated primary screening with staff focused on alerts |
| Imaging or alternative sensor system | Performance, privacy, speed, and deployment requirements vary | Integrated people-and-bag workflow with cloud fleet management |
| No formal screening | Lowest direct cost but less structured entrance risk control | A less disruptive screening experience intended for everyday venues |
Where is the moat still unproven?
A durable moat requires renewals, pricing power, reliable detection, dependable manufacturing, and customer trust. Management estimates nearly 400,000 potential sites and about 700,000 thresholds, but that is a company estimate, not established market share. Retention and cash economics remain better tests than screening volume alone.
Why is Evolv's security-as-a-service model capital intensive?
Pure subscriptions require Evolv to fund systems and recover the investment over multi-year contracts. At March 31, 2026, net leased equipment was $98.9M and gross leased equipment was $148.6M; future noncancelable lease payments totaled $218.1M. These assets support recurring revenue but explain why ARR growth can consume cash.
What does the balance sheet say?
| Balance-sheet or cash item | Latest value | Period | Interpretation |
|---|---|---|---|
| Cash and marketable securities | $61.1M | March 31, 2026 | Liquidity cushion, down from $69.0M at FY2025 year-end |
| Long-term debt, net | $28.7M | March 31, 2026 | $30M principal drawn; approximately 8.92% interest rate |
| Unused debt facilities | $45.0M | March 31, 2026 | $30M delayed draw plus $15M revolving availability, subject to terms |
| Accounts receivable | $42.7M | March 31, 2026 | Up from $30.8M at year-end, increasing working-capital attention |
| Deferred revenue | $92.4M | March 31, 2026 | Contract cash and billing visibility not yet recognized as revenue |
| Remaining performance obligations | $293.6M | December 31, 2025 | Multi-year contracted revenue visibility; $127.1M expected within one year |
How strong was the FY2025 baseline?
FY2025 gross profit was $75.3M, operating loss $(48.5)M, net loss $(33.1)M, and ending ARR $120.5M. Positive operating cash flow was meaningful, but $31.4M of PP&E purchases and $5.6M of internal software investment kept post-investment cash negative. Liquidity depends on equipment spending, receivables, inventory, renewals, and covenant headroom—not accounting earnings alone.
Who owns EVLV stock, and how is the company governed?
Evolv has one Class A share class with one vote per share and no outstanding preferred stock in the 2026 proxy. Governance is nevertheless partly entrenched: the board has three classes, and removal requires cause plus a two-thirds vote. The 2026 proxy statement reported 179.4M shares outstanding as of March 20, 2026.
| Holder or group | Beneficial ownership | Proxy snapshot | Why it matters |
|---|---|---|---|
| The Vanguard Group | 12.0M shares / 6.7% | March 20, 2026 | Large passive influence; later filing noted internal ownership disaggregation |
| BlackRock | 9.4M shares / 5.2% | March 20, 2026 | Another significant institutional voting block |
| Directors and executive officers as a group | 9.6M shares / 5.2% | March 20, 2026 | Includes exercisable options, linking management economics to equity value |
| Michael Ellenbogen | 4.6M shares / 2.5% | March 20, 2026 | Founder ownership retains economic alignment without voting control |
| Anil Chitkara | 3.2M shares / 1.8% | March 20, 2026 | Founder stake remains meaningful but not controlling |
What do leadership incentives emphasize?
John Kedzierski became chief executive in December 2024 after more than 23 years at Motorola Solutions, a background relevant to channel management and enterprise security operations. The appointment announcement framed the transition around scaling the business and strengthening operations.
The 2025 incentive scorecard weighted revenue at 40%, plan-defined free cash flow at 30%, and adjusted EBITDA at 30%. Results produced 147.5% aggregate achievement. The balance is sensible, but researchers should reconcile non-GAAP compensation metrics to cash statements and monitor dilution: shares rose from 159.6M at FY2024 year-end to 175.4M at FY2025 year-end, while FY2025 stock compensation was $21.1M.
Which KPIs best explain Evolv's performance?
Revenue alone can misread Evolv because contract structure changes recognition timing and equipment funding. A useful dashboard combines ARR, RPO, deployments, customer additions, mix, stream margins, retention, and cash investment. ARR and RPO describe future economics; neither is revenue or cash.
| KPI | Latest disclosed value | How to calculate or read it | What a stronger signal looks like |
|---|---|---|---|
| ARR | $127.3M, March 31, 2026 | Annualized recurring contract value at period end | Growth with stable retention and rising recurring gross profit |
| Recurring revenue share | 67.3%, Q1 2026 | $31.2M recurring revenue divided by $46.3M total revenue | Healthy recurring mix without constraining customer purchase options |
| RPO | $293.6M, December 31, 2025 | Contracted consideration not yet recognized as revenue | Growth that converts predictably to revenue and cash |
| New end-users | 48, Q1 2026 | New customer logos added during the quarter | Broad additions plus expansion within existing accounts |
| Gross margin | 50.9%, Q1 2026 | Gross profit divided by revenue | Stable or rising margin as hardware volume and service scale grow |
| Post-investment cash use | $(8.1)M, Q1 2026 | Operating cash flow less PP&E and internal software development | Movement toward sustained positive cash after deployment investment |
Which metrics should move together?
Why are renewals the next critical proof point?
Contracts commonly begin with a noncancelable term of about four years. As the fleet matures, renewals will reveal switching costs, satisfaction, pricing power, equipment-life assumptions, and refurbishment economics. Evolv does not yet provide a mature net-revenue-retention series, making future renewal disclosure especially valuable.
What opportunities and risks could change Evolv's outlook?
Management estimates nearly 400,000 potential sites and about 700,000 thresholds across education, healthcare, entertainment, workplaces, government, hospitality, and worship. Growth can come from new customers, more entrances, eXpedite, upgrades, international channels, analytics, and integrations. The SAFETY Act designation for eXpedite may support procurement trust, but does not remove operating or legal risk.
Which opportunities have the highest strategic value?
What risks are most material?
Controls connect accounting, litigation, governance, and financing. Evolv said Q1 2026 disclosure controls were ineffective because material weaknesses remained. The DOJ told the company in August 2025 it was no longer a subject of its investigation, while the SEC matter remained open. These are unresolved risks, not proof of either an all-clear or wrongdoing.
Why does Evolv matter for valuation, and what is the key takeaway?
A simple revenue multiple misses Evolv's contract mix. A DCF should separate recurring software and service economics from low-margin product revenue, then model equipment funding for pure subscriptions. Key variables are ARR, renewals, margins, operating leverage, receivables, leased-equipment capex, dilution, debt cost, and legal or control risk.
What should a DCF model distinguish?
The scorecard is a research synthesis, not a credit rating. A base case would assume continued customer growth, margin improvement, and lower cash intensity per deployment. A conservative case would use weaker renewals, low hardware margins, more equipment investment, and slower control remediation. Terminal value must reflect mature free cash flow after replacement investment, not ARR alone.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
